Top

Journal of Diabetes & Metabolic Disorders

Published in:

01-12-2020 | COVID-19 | Commentary

Non-communicable Diseases and COVID-19; a double-edged sword A Special Communication from IRAN

Authors: Niloofar Peykari, Sana Eybpoosh, Hamidreza Safikhani, Ali Akbar Haghdoost, Ozra Tabatabaei-Malazy, Bagher Larijani

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2020

Excerpt

The novel coronavirus disease (COVID-19) affected 8,366,417 people, and caused 450,087 deaths over the time up to 19 June 2020 [1]. Nearly 856,650 confirmed cases of covid-19 were related to Eastern Mediterranean region [1]. The COVID-19 crisis affected Iran similar to other countries in the world and region, and 184,955 confirmed cases reported till 13 June 2020 in Iran [2]. …

WHO. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/. 2020.

National Committee on COVID-19 Epidemiology MoHaME. http://corona.behdasht.gov.ir/files/site1/files/IRAN_COVID19_Factsheet_N.45_-13June_En.pdf. 2020.

Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med. 2013;369(14):1336–43.CrossRef

GBD compare. Avaialble at: https://vizhub.healthdata.org/gbd-compare/.

Baradaran A, Ebrahimzadeh MH, Baradaran A, Kachooei AR. Prevalence of comorbidities in COVID-19 patients: a systematic review and meta-analysis. Arch Bone Jt Surg. 2020;8:247–55.PubMedPubMedCentral

Chen QQ, Zheng ZC, Zhang C, Zhang XJ, Wu HJ, Wang JD, et al. Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China. Infection. 2020;48(4):543–51. https://doi.org/10.1007/s15010-020-01432-5.CrossRefPubMed

Chen T, Wu D, Chen HL, Yan WM, Yang DL, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1295. https://doi.org/10.1136/bmj.m1295.CrossRef

Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8(1):e35.PubMedPubMedCentral

Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14(3):247–50.CrossRef

10.

Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259–60. https://doi.org/10.1038/s41569-020-0360-5.CrossRefPubMed

11.

Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–8. https://doi.org/10.1007/s00134-020-05991-x.CrossRefPubMed

12.

Yang C, Jin Z. An acute respiratory infection runs into the most common noncommunicable epidemic - COVID-19 and cardiovascular diseases. JAMA Cardiol. 2020;5(7):743–4. https://doi.org/10.1001/jamacardio.2020.0934.CrossRefPubMed

13.

Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020;14(3):211–2. https://doi.org/10.1016/j.dsx.2020.03.002.CrossRefPubMedPubMedCentral

14.

Brufsky A. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic. J Med Virol. 2020;92(7):770–5. https://doi.org/10.1002/jmv.25887.CrossRefPubMed

15.

Maddaloni E, Buzzetti R. Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020:e33213321. https://doi.org/10.1002/dmrr.3321.

16.

Wang XH, Fang XX, Cai ZX, Wu XT, Gao XT, Min JX, et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis. Research (Wash D C). 2020;2020:2402961. https://doi.org/10.34133/2020/2402961.CrossRef

17.

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42. https://doi.org/10.1001/jama.2020.2648.CrossRefPubMed

18.

Wang WQ, Lu JL, Gu WQ, Zhang YF, Liu JM, Ning G. Care for diabetes with COVID-19: advice from China. J Diabetes. 2020;12(5):417–9. https://doi.org/10.1111/1753-0407.13036.CrossRefPubMed

19.

Trapani D, Marra A, Curigliano G. The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy region. Eur J Cancer. 2020;132:199–206.CrossRef

20.

Desai A, Sachdeva S, Parekh T, Desai R. COVID-19 and cancer: lessons from a pooled meta-analysis. JCO Glob Oncol. 2020;6:557–9. https://doi.org/10.1200/GO.20.00097.CrossRefPubMed

21.

Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21(4):e181. https://doi.org/10.1016/S1470-2045(20)30149-2.CrossRefPubMedPubMedCentral

22.

Sidaway P. COVID-19 and cancer: what we know so far. Nat Rev Clin Oncol. 2020;17(6):336. https://doi.org/10.1038/s41571-020-0366-2.CrossRefPubMed

23.

Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–7.CrossRef

24.

Tal-Singer R, Crapo JD. COPD at the time of COVID-19: a COPD Foundation perspective. Chronic Obst Pulm Dis. 2020;7(2):73–5.

25.

Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, et al. The impact of COPD and smoking history on the severity of Covid-19: a systemic review and meta-analysis. J Med Virol. 2020. https://doi.org/10.1002/jmv.25889.

26.

Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020;15(5):e0233147. https://doi.org/10.1371/journal.pone.0233147.CrossRefPubMedPubMedCentral

27.

Kaye L, Theye B, Smeenk I, Gondalia R, Barrett MA, Stempel DA. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020;8(7):2384–5.CrossRef

28.

National Committee on COVID-19 Epidemiology, Ministry of Health and Medical Education, IR Iran. Daily situation report on coronavirus disease (COVID-19) in Iran; march 23, 2020. Arch Acad Emerg Med. 2020;8(1):e36.

29.

Kluge HHP, Wickramasinghe K, Rippin HL, Mendes R, Peters DH, Kontsevaya A, et al. Prevention and control of non-communicable diseases in the COVID-19 response. Lancet. 2020;395(10238):1678–80.CrossRef

30.

Rapid assessment of service delivery for NCDs during the COVID-19 pandemic. Available at: https://www.who.int/publications/m/item/rapid-assessment-of-service-delivery-for-ncds-during-the-covid-19-pandemic. Last Access: 29 May 2020.

31.

Deng SQ, Peng HJ. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J Clin Med. 2020;9(2). https://doi.org/10.3390/jcm9020575.

32.

Tin STW, Vivili P, Na’ati E, Bertrand S, Kubuabola I. Insights in public health: COVID-19 special column: the crisis of non-communicable diseases in the Pacific and the coronavirus disease 2019 pandemic. Hawaii J Health Soc Welf. 2020;79(5):147–8.

33.

Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, et al. National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. Journal of Diabetes & Metabolic Disorders. 2017;16(1):3. https://doi.org/10.1186/s40200-017-0288-4.

34.

Peykari N, Larijani B. A multi-sectoral approach to combatting non-communicable diseases: Iran’s experience. Journal of Diabetes & Metabolic Disorders. 2019;18(2):719–20.CrossRef

Title: Non-communicable Diseases and COVID-19; a double-edged sword A Special Communication from IRAN
Authors: Niloofar Peykari
Sana Eybpoosh
Hamidreza Safikhani
Ali Akbar Haghdoost
Ozra Tabatabaei-Malazy
Bagher Larijani
Publication date: 01-12-2020
Publisher: Springer International Publishing
Keywords: COVID-19
Chronic Obstructive Lung Disease
Published in: Journal of Diabetes & Metabolic Disorders / Issue 2/2020
Electronic ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-020-00683-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2020

Prevalence of cardiometabolic syndrome in HIV-infected persons: a systematic review

Effect of ertugliflozin on glycemic levels, blood pressure and body weight of patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Effectiveness of acceptance and commitment therapy (ACT) on depression and sleep quality in painful diabetic neuropathy: a randomized clinical trial

Evaluation of biomarkers in liver following Solanum melongena green calyx administration in diabetic rats

Cross-sectional survey on the diabetes knowledge, risk perceptions and practices among university students in South Jordan

A brief analysis and hypotheses about the risk of COVID-19 for people with type 1 and type 2 diabetes mellitus

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage